SFL participating in BIO International Convention
SFL’s CEO, Shayesteh Fürst-Ladani, and SFL Pharma’s General Manager, François Bersier, will participate in the 2018 BIO International Convention, taking place in Boston, USA, on 4-7 June 2018. This year, BIO will celebrate its 25th anniversary with a program covering the latest developments in the biotechnology and pharmaceutical industries. Key topics that are also covered by SFL’s longstanding experience will include gene therapy, precision medicines, digital health, regulatory innovation and patient access.
In addition, SFL Pharma provides full support to pharma companies, who do not have a registered subsidiary in Switzerland, by acting as their Marketing Authorization Holder (MAH). Please get in touch with us to arrange a meeting with Shayesteh or François during the BIO International Convention.